Lenvatinib
From IDWiki
- Multiple receptor tyrosine kinase inhibitor (TKI) that inhibits VEGF receptors
- Indicated for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma
- Hypertension is a common side effect
- Other adverse effects include heart failure, QT prolongation, renal failure, proteinuria, diarrhea, poor wound healing and fistula formation
